Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
Video content above is prompted by the following questions:
What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?